Korro Bio, Inc. 8-K

What Happened
Korro Bio, Inc. (NASDAQ: KRRO) announced that it hosted a virtual Analyst Day on January 27, 2026 and filed selected presentation slides from that event as Exhibit 99.1 to a current report on Form 8-K (Item 8.01). The filing also includes the Inline XBRL cover page file (Exhibit 104) and incorporates the slides by reference.

Key Details

• Analyst Day date: January 27, 2026.
• Exhibit filed: 99.1 — "Selected Slides from Analyst Day Presentation of Korro Bio, Inc., dated January 27, 2026."
• Form 8-K items reported: Item 8.01 (Other Events) and Item 9.01 (Financial Statements and Exhibits).
• The filing does not report earnings, revenue figures, executive changes, mergers, or other material corporate actions.

Why It Matters
Filing the Analyst Day slides gives investors direct access to management’s presentation on strategy, pipeline, milestones or outlook (as presented in the slides). While the 8-K supplies the presentation materials, it does not itself announce financial results, officer appointments, or transactions — investors should review the attached slides for specific business updates and await any separate filings for formal financial disclosures or material corporate actions.